An acquired partial pituitary insufficiency with selective ACTH and GH deficiency was demonstrated in two men aged 47 and 54, for which the clinical course over many years corresponds to Addison's disease.
Until recently, only 5 adult cases of both ACTH and GH deficiency have been reported (Ishikawa et al., 1985; Sekiya et al., 1984; Smallridge et al., 1980; Suzuki et al., 1980; Zielsen et al., 1978) , although such deficiency is not so rare in children (Goodman et al., 1968; Haymond et al., 1976) . Hochberg et al. (1985) documented a nine-year-old girl with a severe hypoglycemic coma, who proved to have isolated ACTH deficiency. On the initial evaluation, before any treatment, GH did not respond to provocation stimuli, but during replacement therapy with hydrocortisone normal linear growth was observed. Repeated testing while on glucocorticoid replacement for four years after the initial examination In a 55-year-old man basal GH ranged from <0.3 ng/ml (0.7-4.7 ng/ml) to 0.5 ng/ml and arginine and L-dopa tests caused no increase in serum GH, as shown in (Mashito et al., 1981) and 7 of 37 cases (Kamijo et al., 1982) .
As to the hypothesis of hormone inbalance accompaniedwith ACTH deficiency, a high basal TSH concentration was pointed out in 12 of 17 cases and an exaggerated TSH response to TRH in 13 of 27 cases (Mashito et al., 1981) , as observed in case 2. In addition, hyperprolactinemia was observed in 2 of 9 cases with isolated ACTH deficiency.
In our case of isolated ACTH deficiency, subnormal GH response to insulin tolerance test and glucagon-propranolol test was observed, although arginine stimulation and L-dopa test elicited no increase in serum GH. The case reported by Hochberg et al., showed subnormal GH responses to an insulin-induced hypoglycemia test and no GH response to L-dopa prior to hydrocortiosne replacement. From these results, it is reasonable to conclude that a comparison of data on GH stimulation tests before and during hydrocortisone treatment was of great diagnostic importance.
The correlation between glucocorticoid and GH secretion involves a number of perplexing problems. It is also demonstrated that in in vitro studies glucocorticoid stimulates GH secretion from pituitary glands due to an increase in GH gene transcription as well as GH release (Dobner et al., 1981) . In contrast, in in vivo studies it has been found that glucocorticoid inhibits GH secretion and its response to various stimuli is due to both an increase in somatostatin secretion and a decrease in GHRH secretion from the hypothalamus (Nakagawa et al., 1987) . Finally, the overall effect of cortisol or glucocorticoid on GH secretion in an in vivo system must be decided with reference to the difference between the stimulatory effect at pituitary GH cells and the inhibitory effect at the hypothalamus. And so it is reasonable to point out the possibility that in cases with hypothalamic ACTH deficiency accompanying hypothalamic dysfunction, i.e. in the state of somatostatin and GHRH deficiency, glucocoriticoid could stimulate GH secretion through its direct action at pituitary GH cell. This hypothesis can also explain why transient GH deficiency is not so common in patients with isolated ACTH deficiency, as already reported (Mashito et al., 1981) . Further investigation is necessary to determine why substitution doses of cortisol correct GH responses in some patients with isolated ACTH deficiency associated with transient GH insufficiency.
Another possible explanation is that hydrocortisone replacement resumed GH secretion through by alleviating immunological inflamation which must play a central role in the pathogenesis of isolated ACTH deficiency (Richtmeier et al., 1980 Kamijo et al., 1982 , although pituitary adrenal insufficiency still remains uuchanged.
With respect to the pathogenesis of both ACTH and GH deficiency, immunological changes seemed to be involved because in our case antibodies to anterior pituitary cell membranes were demonstrated.
